AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Harris & Harris Group, Inc., announced it has invested $525,900 as part of a convertible preferred financing of privately held Chlorogen, Inc.
Investors in this financing include Burrill & Co., Redmont Venture Partners, and Prolog Venture Partners.
Chlorogen is focused on developing plant-made drugs and vaccines for the treatment and prevention of human diseases.
Its patented chloroplast technology permits the expression of foreign proteins only within plant chloroplasts. According to Chlorogen, this provides two significant benefits. First, the chloroplast ...